Found: 8
Select item for more details and to access through your institution.
Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease: A Single‐Center Study of 30 Patients.
- Published in:
- Movement Disorders Clinical Practice, 2024, v. 11, n. 2, p. 159, doi. 10.1002/mdc3.13926
- By:
- Publication type:
- Article
Single‐Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa‐Carbidopa Intestinal Gel.
- Published in:
- Movement Disorders Clinical Practice, 2022, v. 9, n. 1, p. 60, doi. 10.1002/mdc3.13361
- By:
- Publication type:
- Article
Real-Life Experience on Directional Deep Brain Stimulation in Patients with Advanced Parkinson's Disease.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 8, p. 1224, doi. 10.3390/jpm12081224
- By:
- Publication type:
- Article
Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.
- Published in:
- Brain & Behavior, 2021, v. 11, n. 12, p. 1, doi. 10.1002/brb3.2408
- By:
- Publication type:
- Article
Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
- Published in:
- Brain & Behavior, 2017, v. 7, n. 7, p. n/a, doi. 10.1002/brb3.737
- By:
- Publication type:
- Article
Clinical and Brain Morphometry Predictors of Deep Brain Stimulation Outcome in Parkinson's Disease.
- Published in:
- Brain Topography, 2024, v. 37, n. 6, p. 1186, doi. 10.1007/s10548-024-01054-2
- By:
- Publication type:
- Article
Validation of the Finnish Version of the Unified Dyskinesia Rating Scale.
- Published in:
- European Neurology, 2021, v. 84, n. 6, p. 444, doi. 10.1159/000517369
- By:
- Publication type:
- Article
Gut microbiota are related to Parkinson's disease and clinical phenotype.
- Published in:
- Movement Disorders, 2015, v. 30, n. 3, p. 350, doi. 10.1002/mds.26069
- By:
- Publication type:
- Article